Hyperkalemia is usually seen in patients with chronic kidney disease (CKD) when renal excretion of potassium (K + ) is reduced below the level of intake. Normal K + intake does not cause hyperkalemia despite a progressive fall in glomerular filtration rate (GFR) until a critically low level, usually less than 25 mL/min, is achieved (Batlle et al., 1981) . This is due to adaptive mechanisms that permit the excretion of a normal daily K + load despite reduced GFR. Part of this adaptation involves the release of aldosterone from the adrenal glands. Aldosterone acts on the kidney promoting K + secretion. When the release of aldosterone is reduced -as in patients with idiopathic hypoaldosteronism or during the administration of renin angiotensin system (RAS) blockers or aldosterone antagonists -hyperkalemia often develops. In fact, the therapeutic use of these agents in patients with CKD, diabetic nephropathy or congestive heart failure is often limited by the development of hyperkalemia as a potentially dangerous side-effect. Since hyperkalemia usually develops as a result of reduced renal K + secretion, the question that arises is: can we rely on amplification of colonic K + excretion as a route of external disposal? There are a number of similarities and differences between colonic and kidney K + secretion. Two types of apical membrane K + channels that permit K + secretion have been identified. The renal outer medullary K + channel (ROMK) is a low conductance K + channel which is present in the kidney (Wade et al., 2011; Frindt and Palmer, 2010) . The large conductance K + channel (BK), is present in both principal and intercalated cells in the kidney (Najjar et al., 2005) and also in the colon (Sausbier et al., 2006) . Aldosterone stimulates the Epithelial Sodium Channel (ENaC), causing a negative transepithelial potential and increasing the driving force for K + secretion via the ROMK channel. In the colon, the BK channel is the channel present in the apical site where it mediates K + secretion. There is also active transport of K + across basolateral membrane through Na-K-ATPase and Na-K-2Cl cotransport into cells. A negative potential difference across the colonic luminal membrane and the high intracellular K + also facilitate secretion of K + through the BK channel. K + absorption occurs in the distal colon as a result of active translocation of K + via a colonic H-K-ATPase.
The colon normally accounts for a small portion, about 5%, of total K + elimination, whereas the kidneys account for the remaining 95%.
The colon, however, can become a significant site of K + excretion when renal function decreases markedly. Similar to renal adaptive changes, colonic adaptive changes take place including: an increase in Na-K-ATPase activity, a rise in basal K + secretion and an increase in transmural potential difference. These changes are mediated by aldosterone-dependent and independent mechanisms. An increase in K + secretory capacity of rectal mucosa has been demonstrated in patients with advanced CKD (Sandle et al., 1986 (Bakris et al., 2015; Weir et al., 2015) . ) throughout the GI tract but preferentially binds K + in the colon with a net effect of facilitating its fecal excretion (Weir et al., 2015 
